相似文献
1
Expression of CXCL12-CXCR4/CXCR7 chemokines in splenic fibrosis of cirrhotic spleen and its therapeutic significance.
Arch Med Sci. 2023 Aug 25;19(5):1569-1575. doi: 10.5114/aoms/170910. eCollection 2023.
2
[Role of CXCL12-CXCR4/CXCR7 signal axis in liver regeneration and liver fibrosis].
Zhonghua Gan Zang Bing Za Zhi. 2021 Sep 20;29(9):900-903. doi: 10.3760/cma.j.cn501113-20200721-00403.
3
CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
Int J Mol Sci. 2021 Jul 9;22(14):7371. doi: 10.3390/ijms22147371.
4
Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
BMC Cancer. 2015 Mar 31;15:204. doi: 10.1186/s12885-015-1201-5.
5
Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Tumour Biol. 2016 Jun;37(6):8169-79. doi: 10.1007/s13277-015-4686-2. Epub 2015 Dec 29.
6
Differential effects of CXCR4-CXCL12- and CXCR7-CXCL12-mediated immune reactions on murine P0106-125 -induced experimental autoimmune neuritis.
Neuropathol Appl Neurobiol. 2013 Dec;39(7):772-87. doi: 10.1111/nan.12039.
7
CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.
Tumour Biol. 2016 Jan;37(1):567-75. doi: 10.1007/s13277-015-3803-6. Epub 2015 Aug 2.
8
Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
J Transl Med. 2012 Apr 2;10:68. doi: 10.1186/1479-5876-10-68.
9
CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.
Oncotarget. 2016 Apr 5;7(14):18865-75. doi: 10.18632/oncotarget.7738.
10
The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
Br J Dermatol. 2016 Dec;175(6):1210-1220. doi: 10.1111/bjd.14720. Epub 2016 Sep 13.
引用本文的文献
1
Signaling molecules in the microenvironment of hepatocellular carcinoma.
Funct Integr Genomics. 2024 Aug 29;24(5):146. doi: 10.1007/s10142-024-01427-7.
本文引用的文献
1
The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies.
Semin Cancer Biol. 2020 Oct;65:176-188. doi: 10.1016/j.semcancer.2019.12.007. Epub 2019 Dec 23.
2
Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice.
PLoS One. 2016 Mar 21;11(3):e0151765. doi: 10.1371/journal.pone.0151765. eCollection 2016.
3
Inhibition of Janus kinase-2 signalling pathway ameliorates portal hypertensive syndrome in partial portal hypertensive and liver cirrhosis rats.
Dig Liver Dis. 2015 Apr;47(4):315-23. doi: 10.1016/j.dld.2014.12.017. Epub 2015 Jan 12.
4
Grading of peripheral cytopenias caused by nonalcoholic cirrhotic portal hypertension and its clinical significance.
Cell Biochem Biophys. 2015 Mar;71(2):1141-5. doi: 10.1007/s12013-014-0321-x.
5
Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer.
Oncol Rep. 2014 Dec;32(6):2760-8. doi: 10.3892/or.2014.3536. Epub 2014 Oct 10.
6
Subtotal splenectomy for splenomegaly in cirrhotic patients.
Int J Clin Exp Pathol. 2014 Jul 15;7(8):4981-90. eCollection 2014.
7
[What is the spleen needed for?].
Ther Umsch. 2013 Mar;70(3):147-51. doi: 10.1024/0040-5930/a000382.
8
Touch of chemokines.
Front Immunol. 2012 Jul 12;3:175. doi: 10.3389/fimmu.2012.00175. eCollection 2012.
9
Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis.
Exp Mol Med. 2010 Jun 30;42(6):465-72. doi: 10.3858/emm.2010.42.6.048.
10
The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis.
J Leukoc Biol. 2009 Nov;86(5):1111-8. doi: 10.1189/jlb.0309132. Epub 2009 Jul 6.
Zotero 插件
